Program
Cancer therapy-related cardiac dysfunction: Collaboration with Oncology
May 24, 2024 from 12:10pm MDT to 12:40pm MDT
Statement of purpose: The purpose of this abstract is to present the topic of cancer therapy-related cardiac dysfunction in women undergoing systemic therapy for HER 2 + breast cancer.
Description of the issue: Cancer therapy-related cardiac dysfunction (CTRCD) is a relatively common side effect of anthracycline and -2 targeted therapies affecting 9-20% of cancer survivors (Guglin, et al., 2019). CTRCD is a decrease in left ventricular ejection fraction (LVEF) by greater than 10% to an abnormal value, generally less than 53 % (Lyon, et al., 2022). The incidence of CTRCD can vary depending on the patient’s cardiac risk factors and cancer therapies. An overview of the risk factors, pathophysiology, diagnostics, treatment, and surveillance of CTRCD will be presented. Future directions in the nursing management of CTRCD will be reviewed.
Summary of conclusions: Collaboration between cardiology and oncology is critical in the early detection and treatment of CTRCD. Early identification and treatment of CTRCD and completion of cancer therapies can result in >80% of patients recovering their heart function (Thavendiranathan, et al., 2021).
Description of significance and implications for practice. This early identification and treatment of CTRCD allow patients to continue their potentially cardiotoxic cancer therapies without interruption of treatment. Preventing interruptions in cancer therapies improves overall survival, decreases the risk of recurrence, and improves prognosis.
Speakers / Panelists
-
Cancer therapy-related cardiac dysfunction: Collaboration with Oncology
May 24, 2024 from 12:10pm MDT to 12:40pm MDT
Coleen Power
NP, MN, MPH
Coleen Power
Coleen Power
NP, MN, MPH
Coleen Power NP MN MPH has been the nurse practitioner in the cardio oncology program at University Health Network/Ted Rogers Center for Heart Research in Toronto, Ontario since May 2020. She is a graduate of the BScN program at St. Francis Xavier University, MN/NP program Dalhousie University, cardiovascular nurse practitioner program at Duke University, and holds a masters of public health degree from the University of Edinburgh. Currently she is pursuing a PhD in nursing at Queens University. Her cardiac background includes previous experience in general cardiology, heart failure, and cardiovascular surgery. Coleen is deeply committed to providing quality nursing care to all patients. She is excited to be in Calgary this spring and is honoured to be part of this program.